Skip to main content
Important notice

Warning – Fraudulent Calls

Several persons have received fraudulent calls impersonating RAMQ. If you do not have a pending request with us or if the call seems suspicious, do not provide any personal information. Make a note of the agent’s name, end the conversation and call us. To find out more, refer to Our communication practices webpage.

Important information

The contents of this webpage are in French only.

Find out whether a drug is covered

Over 8,000 prescription drugs are covered under the Public Prescription Drug Insurance Plan. They are included on a regularly updated list. Other drugs not on the list may also be covered on an exceptional basis.

Prescription drug search

Disclaimer : Search results do not have the same value as a legal document. To access the relevant legal document, please refer to the List of Medications.

Med-Brimonidine

Covered
  • Active ingredient(s):
  • Manufactured by:
    Generic Medical Partners Inc. (GMP)
  • Strength and dosage form:
    Ophtalmic Solution 0.2 % DIN : 2507811

Riva-Brimonidine

Covered
  • Active ingredient(s):
  • Manufactured by:
    Laboratoire Riva Inc. (Riva)
  • Strength and dosage form:
    Ophtalmic Solution 0.2 % DIN : 2515350

Sandoz Brimonidine

Covered
  • Active ingredient(s):
  • Manufactured by:
    Sandoz Canada Inc (Sandoz)
  • Strength and dosage form:
    Ophtalmic Solution 0.2 % DIN : 2305429

Solution ophtalmique de tartrate de brimonidine

Covered
  • Active ingredient(s):
  • Manufactured by:
    Hikma Canada Limited (Hikma)
  • Strength and dosage form:
    Ophtalmic Solution 0.2 % DIN : 2515377

Apo-Brimonidine-Timop

Covered

Combigan

Covered

JAMP Brimonidine/Timolol

Covered

Azopt

Covered
  • Active ingredient(s):
  • Manufactured by:
    Novartis Pharma Canada Inc (Novartis)
  • Strength and dosage form:
    Ophtalmic Suspension 1 % DIN : 2238873

Simbrinza

Covered
  • Active ingredient(s):
  • Manufactured by:
    Novartis Pharma Canada Inc (Novartis)
  • Strength and dosage form:
    Ophtalmic Suspension 1 % - 0.2 % DIN : 2435411

Azarga

Covered
  • Active ingredient(s):
  • Manufactured by:
    Novartis Pharma Canada Inc (Novartis)
  • Strength and dosage form:
    Ophtalmic Suspension 1 % -0.5 % DIN : 2331624

How did we do?

Was the information on this page useful to you?
Do not include any personal information. You will not receive any reply.